JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

Enphase Energy (NASDAQ:ENPH) -4.7% in Tuesday's trading as J.P. Morgan downgraded shares to Neutral from Overweight with a ...

JPMorgan’s second-quarter profit fell to $14.2 billion in second quarter, but the New York bank beat Wall Street expectations ...

Fintel reports that on July 15, 2025, JP Morgan upgraded their outlook for Otis Worldwide (NYSE:OTIS) from Neutral to ...

Investing.com -- J.P. Morgan has named AngloGold Ashanti its top pick among EMEA gold miners, replacing Fresnillo (LON: FRES ...

CDL's group CEO Sherman Kwek is now in a better position to streamline CDL’s business and close the discount to book value ...

The Nasdaq Composite advanced to its latest record high on Tuesday, powered by a jump in heavyweight Nvidia's shares, while ...

JP Morgan CEO Jamie Dimon warned that President Trump's trade policies may pose significant risks to the US economy. He highlighted ongoing concerns related to tariffs, trade uncertainty, and ...

Telix Pharmaceuticals shares have one of the best 5 year track records on the ASX. Can this continue according to JP Morgan?

JPMorgan’s chief, Jamie Dimon, lauded the “resilient” U.S. economy as his bank reported bumper quarterly earnings.

Aegle Therapeutics, a clinical-stage dermatology-focused biopharmaceutical company developing novel therapies for those ...